SUPERNUS PHARMACEUTICALS, INC.
For the period ended Dec 31, 2025. Filed Mar 2, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 2, 2026
SUPN$28.75+4.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Reports of Independent Registered Public Accounting Firm (PCAOB ID 185) | 103 |
|---|---|
| Consolidated Balance Sheets | 107 |
| Consolidated Statements of Earnings (Loss) | 108 |
| Consolidated Statements of Comprehensive Earnings (Loss) | 109 |
| Consolidated Statements of Changes in Stockholders' Equity | 110 |
| Consolidated Statements of Cash Flows | 111 |
| Notes to Consolidated Financial Statements | 112 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.